Related Experiment Video
Updated: Mar 7, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Longitudinal course of lung function in myotonic dystrophy type 1
Catherine Thil1, Nelly Agrinier2, Bruno Chenuel1
1Department of Pulmonary Function Testing and Exercise Physiology, CHRU Nancy, Nancy, F-54000, France.
Myotonic dystrophy type 1 (DM1) patients experience slowly progressive lung function decline. This study quantifies annual changes in forced vital capacity, forced expiratory volume, and total lung capacity in DM1 individuals.
Area of Science:
- Neurology
- Pulmonology
- Clinical Research
Background:
- Prognosis and quality of life in myotonic dystrophy type 1 (DM1) are significantly influenced by respiratory function.
- Longitudinal changes in pulmonary function in DM1 patients remain incompletely characterized.
Purpose of the Study:
- To describe the long-term progression of pulmonary function over time in patients with myotonic dystrophy type 1.
- To provide quantitative data on annual changes in key lung volumes for DM1 patients.
Main Methods:
- Retrospective analysis of pulmonary function tests.
- Inclusion of 80 DM1 patients with a minimum follow-up of 5 years.
Main Results:
- Average annual decline observed in forced vital capacity (FVC): -0.034 L (-0.72% predicted).
- Average annual decline observed in forced expiratory volume in 1 second (FEV1): -0.043 L (-1.07% predicted).
- Average annual decline observed in total lung capacity (TLC): -0.047 L (-1.15% predicted).
Conclusions:
- Myotonic dystrophy type 1 is associated with a slow, progressive decline in lung function.
- The rate of pulmonary function impairment in DM1 appears gradual compared to other neuromuscular disorders.
More Related Videos
14:10Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
Published on: January 31, 2013
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
Related Concept Videos
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Lung Capacity
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Longitudinal Research